Skip to main content
. 2015 Jul 28;5:10648. doi: 10.1038/srep10648

Figure 5.

Figure 5

Plasma gefitinib concentration at randomization and 60 days thereafter in patients who received 500 mg/d gefitinib or 250 mg/d gefitinib. PR, partal response; PD, progressive disease; SD, stable disease.